For decades, the healthcare industry has lacked a long list of elements necessary to understand the nature of hundreds of rare diseases — industry cohesiveness and data transparency chief amongst them. With the help of PwC and Microsoft, one pioneering group of minds may have finally found a key part of the solution: an open-source approach to medical research.
“We have a lot of smart, motivated, dedicated people together who want to see these patients have a different path. The technology is there for personalized medicine. The technology is there to make advances in rare disease,” says Elizabeth Estes, OSIC executive director.
A discussion with the Open Source Imaging Consortium, Microsoft and PwC: See how data and analytics, AI and cloud will reshape the future of healthcare.
A first-of-its-kind open source medical imaging and data repository platform is highlighting new possibilities to help improve the speed and accuracy of diagnosis and help patients, providers and researchers better manage the disease.